Figure 3.

Age-adjusted incidence rates of invasive (solid lines) and in situ (dashed lines) breast cancer according to hormone therapy use at follow-up in 2000-2001 among menopausal women 50 years or older in the California Teachers Study. E = estrogen only hormone therapy; EP = estrogen-progestin hormone therapy; HT = Hormone therapy.

Marshall et al. Breast Cancer Research 2010 12:R4   doi:10.1186/bcr2467
Download authors' original image